Recital 4, Regulation (EU) 2022/1646

In forcesince 23 Sep 2022

Regulation (EU) 2019/6 of the European Parliament and the Council [Regulation (EU) 2019/6 of the European Parliament and the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (OJ L 4, 7.1.2019, p. 43).] establishes the regulatory framework for the placing on the market, manufacturing, import, export, supply, distribution, pharmacovigilance, control and the use of veterinary medicinal products. Furthermore, pharmacologically active substances, which are not authorised in veterinary medicinal products, may not be used in food-producing animals in the EU, with the exception of substances that are essential for the treatment of equine animals as provided for in Commission Regulation (EC) No 1950/2006 [Commission Regulation (EC) No 1950/2006 of 13 December 2006 establishing, in accordance with Directive 2001/82/EC of the European Parliament and of the Council on the Community code relating to veterinary medicinal products, a list of substances essential for the treatment of equidae and of substances bringing added clinical benefit (OJ L 367, 22.12.2006, p. 33).].